IDEXX Laboratories shared earlier this month the launch of IDEXX Cancer Dx, a diagnostic panel with early detection of ...

The department said it was hopeful it would take several more months, but "the time has come to put him to sleep." ...

As pet owners, we dread the day our companions show signs of illness, but a vet has explained everything you need to know.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of IDEXX Cancer Dx™, a first-of-its-kind diagnostic panel with early detection of ...

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...

IDEXX Laboratories launches Cancer Dx panel for early detection of canine lymphoma: Westbrook, Maine Friday, January 24, 2025, 16:00 Hrs [IST] IDEXX Laboratories, Inc., a global l ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

Shares of leading pet healthcare diagnostics provider Idexx Laboratories (NASDAQ: IDXX) were up by 9% this week as of 4 p.m. ET Thursday, according to data provided by S&P Global ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.

IDEXX outlined its 2025 revenue target of $4.055 billion to $4.170 billion, reflecting organic growth of 6% to 9%. The CAG Diagnostic recurring revenue is expected to grow between 5% and 8% ...

Reports Q4 revenue $954M, consensus $936.68M. “IDEXX had a solid finish to 2024, supported by continued high levels of execution by IDEXX teams ...